Comparative Bioavailability Study of 600mg Azithromycin Monohydrate Tablets Under Fasting Conditions
NCT00866216 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 38
Last updated 2017-03-29
Summary
The purpose of this study is to demonstrate the bioequivalence of Azithromycin Monohydrate 600 mg Tablets.
Conditions
Interventions
- DRUG
-
Azithromycin Monohydrate 600mg Tablets Geneva Pharmaceuticals
- DRUG
-
Zithromax (Azithromycin Dihydrate) 600mg Tablets Pfizer Inc.
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Alan S Marion · MDS Pharma
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 19 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2003-08-31
- Primary Completion
- 2003-09-30
- Completion
- 2003-09-30
More Related Trials
-
Relative Bioavailability Study in Healthy Subjects
NCT00924911 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy People to Test How 2 Different Formulations of BI 690517 Are Taken up in the Body and How Probenecid Influences the Amount of BI 690517 in the Blood
NCT06647810 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fasting State
NCT00648960 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Compare the Bioavailability of JNJ-47910382 Formulated as a Tablet and as Suspension in Healthy Participants
NCT01662661 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I 2-Way Crossover Study to Assess Relative BA of Tablet Versus Liquid Suspension and Food Effect on Tablet Formulation
NCT00867685 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Relative Bioavailability of Tablet Formulations of GSK2248761 in Healthy Adult Subjects. SGN114435
NCT01209117 ·Status: COMPLETED ·Phase: PHASE1
-
To Demonstrate the Relative Bioavailability of Clarithromycin 250 mg Tablets Under Fasting Conditions
NCT00881738 ·Status: COMPLETED ·Phase: PHASE1
-
Study of New Tablet Formulations and Suspension Formulation Compared to Current (1B) Formulation of BILR 355 BS in Healthy Male Volunteer Subjects
NCT02259868 ·Status: COMPLETED ·Phase: PHASE1
-
Clarithromycin 500 mg Extended Release Tablets Under Fasting Conditions
NCT00840411 ·Status: COMPLETED ·Phase: PHASE1
-
Clarithromycin 500 mg Extended Release Tablets Under Non-Fasting Conditions.
NCT00840216 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Participants to Investigate Relative Bioavailability of AZD5004 in Three Solid Oral Formulations
NCT06996886 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability Study of PF-07321332/Ritonavir Oral Powder Relative to the Commercial Tablets in Healthy Participants
NCT05263921 ·Status: COMPLETED ·Phase: PHASE1
-
A Bioavailability and Food Effect Study of AZD5462 in Healthy Volunteers
NCT05512806 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability of BMS-626529 in Healthy Subjects From Prototype Low Dose Extended Release Formulations (Part 1) and Prototype Extended Release Multi-particulate Formulations (Part 2) of BMS-663068 Relative to 600 mg Extended Release Tablet
NCT02508064 ·Status: COMPLETED ·Phase: PHASE1
-
To Demonstrate the Relative Bioavailability of Clarithromycin 250 mg Tablets Under Non-Fasting Conditions
NCT00881179 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Examine the Acceptable Taste and to Estimate the Amount of Atazanavir and Cobicistat in the Body When Taken as a Combination Product Versus When Taken as Separate Products at the Same Time
NCT04263350 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Relative Bioavailability of AMG 510 Administered as Tablets and as a Water Dispersion in Healthy Participants
NCT05571163 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Pharmacokinetic Interaction Between Combivir® (ZDV+3TC) and BILR 355 BS Plus Ritonavir in Healthy Subjects
NCT02256774 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability Study With BMS-955176
NCT02095886 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability of BI 1356 After Co-administration With Ritonavir Compared to the Bioavailability of BI 1356 Alone in Healthy Male Volunteers
NCT02183441 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Relative Bioavailability of Three Formulations and Food Effect on GSK1322322 in Healthy Subjects
NCT01648179 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability of ATI-1501 With Taste Test Sub Study
NCT03337126 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability Study of Nirmatrelvir/Ritonavir 4 Different Fixed Dose Combination Tablets Relative to the Commercial Tablets in Healthy Participants
NCT05525910 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Different Boosting Agents on Pharmacokinetics of BILR 355 BS Dissolved in Polyethylene Glycol 400 (PEG 400) in Healthy Male Volunteers
NCT02257008 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Pharmacokinetics and Relative Bioavailability of Metabolites in Healthy Chinese Adult Males
NCT06841926 ·Status: COMPLETED ·Phase: PHASE1